LONDON BROKER RATINGS: Persimmon, Shaftesbury upped; Coca-Cola HBC cut
10th Aug 2026 09:41
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 562.50p on 10-08-2026 at 10:55:18 |
|---|---|
| Change | 9.00p 1.63% |
| Buy | 563.00p |
| Sell | 562.00p |
| Last Trade: | Sell 919.00 at 562.50p |
| Day's Volume: | 367,954 |
| Last Close: | 553.50p |
| Open: | 553.50p |
| ISIN: | GB00B0WMWD03 |
| Day's Range | 550.50p - 564.00p |
| 52wk Range: | 398.60p - 570.00p |
| Market Capitalisation: | £2.88b |
| VWAP: | 558.74898p |
| Shares in Issue: | 512.08m |
Qinetiq (QQ.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 919 | 562.50p | Automatic Execution |
11:55:18 - 10-Aug-26 |
| Sell* | 160 | 562.50p | Automatic Execution |
11:55:18 - 10-Aug-26 |
| Sell* | 265 | 562.50p | Automatic Execution |
11:55:18 - 10-Aug-26 |
| Sell* | 120 | 562.50p | Automatic Execution |
11:53:39 - 10-Aug-26 |
| Sell* | 313 | 562.50p | Automatic Execution |
11:53:39 - 10-Aug-26 |
| Sell* | 126 | 562.50p | Automatic Execution |
11:53:39 - 10-Aug-26 |
| Sell* | 33 | 562.50p | Automatic Execution |
11:53:35 - 10-Aug-26 |
| Sell* | 1,147 | 562.638p | Negotiated Trade |
11:53:06 - 10-Aug-26 |
| Sell* | 2,037 | 562.50p | Ordinary |
11:52:46 - 10-Aug-26 |
| Buy* | 1 | 563.00p | Automatic Execution |
11:52:42 - 10-Aug-26 |
Qinetiq (QQ.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Aug 2026 4:19 pm | RNS | Director/PDMR Shareholding |
| 4th Aug 2026 7:00 am | RNS | Transaction in Own Shares |
| 31st Jul 2026 4:35 pm | RNS | Total Voting Rights |
| 28th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 27th Jul 2026 5:13 pm | RNS | Holding(s) in Company |
| 21st Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Jul 2026 1:09 pm | RNS | Result of AGM |
| 16th Jul 2026 7:00 am | RNS | Q1 Trading Update |
| 14th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Jul 2026 1:42 pm | RNS | Director/PDMR Shareholding |